SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MRE (medco research)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Harold V who wrote (96)6/23/1998 8:06:00 PM
From: Xiaoping Zhang  Read Replies (1) of 192
 
I am thinking about buying this stock, but one thing bothers me - i.e., this company has very low tax rate in the past 5 Qs from 0.86% to 6%. This must be due to their tax credit accrued during previous years (e.g., 1993 - 1995) as a result of operation losses and, partially, due to their R&D expenses which qualify for a lower tax rate. However, in the past couple of years, the company has been in black and they will soon use up their tax credit. When new tax rate kicks in at (say) 36%, the EPS will be slashed downwards as in the case of GNRL and unprepared small investors will get shocked. I have seen several stocks with this problem but have not found any one on this thread discussing it. Am I wrong on this? Any comments are welcome.

X.Z. 6/23/98
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext